There were 1,485 press releases posted in the last 24 hours and 438,421 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Neuralstem Announces Last Subject Enrolled in Phase 2 Trial with NSI-189 for Major Depressive Disorder

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image